Resumen de The Lancet
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Sharpening the global focus on ethnicity and race in the time of COVID-19 Artículos anteriores A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis Access to health care under threat in Afghanistan Offline: COVID-19 and the ethics of memory Attacks against health-care personnel must stop, especially as the world fights COVID-19 Salient lessons from Russia’s COVID-19 outbreak Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study COVIDSurg Collaborative The starting line for COVID-19 vaccine development Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial A history of the medical mask and the rise of throwaway culture Who is most likely to be infected with SARS-CoV-2? Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study Offline: A global health crisis? No, something far worse Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Effect of the COVID-19 pandemic on cancer treatment and research Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study Cancer guidelines during the COVID-19 pandemic Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection COVID-19: protecting health-care workers COVID-19: the medium is the message COVID-19 and Italy: what next? Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic
